Mirugen

Melbourne, Australia

Mirugen is a preclinical biotechnology company identifying the optimal set of cellular instructions to ask one cell type to become another.

$2.9M raised

Aug 2025

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Mirugen raised?

Mirugen has raised $2.9M in total funding. The most recent round was Seed. The last funding was announced in August 2025.

Who are Mirugen's investors?

Mirugen's investors include Brandon Capital, Tin Alley Ventures, Genesis Pre-Seed Fund.

Where is Mirugen headquartered?

Mirugen is headquartered in Melbourne, Australia.

What does Mirugen do?

Mirugen is a preclinical biotechnology company identifying the optimal set of cellular instructions to ask one cell type to become another.

What stage is Mirugen at?

Mirugen is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 13, 2025.

MLA

"Mirugen — Funding & Investors." VCBacked, August 13, 2025, https://www.vcbacked.co/company/mirugen. Accessed July 2, 2026.

APA

VCBacked. (2025). Mirugen — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/mirugen

Wikipedia (cite web)

{{cite web |title=Mirugen — Funding & Investors |url=https://www.vcbacked.co/company/mirugen |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 13, 2025.